Cargando…

Putting the treatment of paediatric schistosomiasis into context

Despite increased international efforts to control schistosomiasis using preventive chemotherapy, several challenges still exist in reaching the target populations. Until recently, preschool-aged children had been excluded from the recommended target population for mass drug administration, i.e. pri...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mduluza, Takafira, Mutapi, Francisca
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Scoping Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5384153/ https://www.ncbi.nlm.nih.gov/pubmed/28388940 http://dx.doi.org/10.1186/s40249-017-0300-8

Ejemplares similares

Pharmacogenetics of Praziquantel Metabolism: Evaluating the Cytochrome P450 Genes of Zimbabwean Patients During a Schistosomiasis Treatment
por: Zdesenko, Grace, et al.
Publicado: (2022)

Association of schistosomiasis and risk of prostate cancer development in residents of Murehwa rural community, Zimbabwe
por: Choto, Emilia T., et al.
Publicado: (2020)

Elimination of schistosomiasis: the tools required
por: Bergquist, Robert, et al.
Publicado: (2017)

Nucleic acid detection in the diagnosis and prevention of schistosomiasis
por: He, Ping, et al.
Publicado: (2016)

Identifying and Evaluating Field Indicators of Urogenital Schistosomiasis-Related Morbidity in Preschool-Aged Children
por: Wami, Welcome M., et al.
Publicado: (2015)

Comparative Assessment of Health Benefits of Praziquantel Treatment of Urogenital Schistosomiasis in Preschool and Primary School-Aged Children
por: Wami, Welcome M., et al.
Publicado: (2016)

Schistosomiasis and soil-transmitted helminthiasis in Rwanda: an update on their epidemiology and control
por: Rujeni, Nadine, et al.
Publicado: (2017)

Critical analysis of molluscicide application in schistosomiasis control programs in Brazil
por: Coelho, PMZ, et al.
Publicado: (2016)

Extent of morbidity associated with schistosomiasis infection in Malawi: a review paper
por: Mtethiwa, Austin H N, et al.
Publicado: (2015)

Approaches being used in the national schistosomiasis elimination programme in China: a review
por: Sun, Le-Ping, et al.
Publicado: (2017)

Controlling schistosomiasis with praziquantel: How much longer without a viable alternative?
por: Bergquist, Robert, et al.
Publicado: (2017)

Epidemiology of pediatric schistosomiasis in hard-to-reach areas and populations: a scoping review
por: Isaiah, Phyllis Munyiva, et al.
Publicado: (2023)

Benefits of annual chemotherapeutic control of schistosomiasis on the development of protective immunity
por: Chisango, Tawanda J., et al.
Publicado: (2019)

Efficacy of praziquantel treatment regimens in pre-school and school aged children infected with schistosomiasis in sub-Saharan Africa: a systematic review
por: Kabuyaya, Muhubiri, et al.
Publicado: (2018)

Moving from control to elimination of schistosomiasis in sub-Saharan Africa: time to change and adapt strategies
por: Tchuem Tchuenté, Louis-Albert, et al.
Publicado: (2017)

The Three Gorges Dam: Does it accelerate or delay the progress towards eliminating transmission of schistosomiasis in China?
por: Zhou, Yi-Biao, et al.
Publicado: (2016)

Paediatric schistosomiasis: What we know and what we need to know
por: Osakunor, Derick N. M., et al.
Publicado: (2018)

Integrated Analysis of Innate, Th1, Th2, Th17, and Regulatory Cytokines Identifies Changes in Immune Polarisation Following Treatment of Human Schistosomiasis
por: Bourke, Claire D., et al.
Publicado: (2013)

Towards interruption of schistosomiasis transmission in sub-Saharan Africa: developing an appropriate environmental surveillance framework to guide and to support ‘end game’ interventions
por: Stothard, J. Russell, et al.
Publicado: (2017)

Schistosomiasis is more prevalent than previously thought: what does it mean for public health goals, policies, strategies, guidelines and intervention programs?
por: Colley, Daniel G., et al.
Publicado: (2017)

Medicalization Defined in Empirical Contexts – A Scoping Review
por: van Dijk, Wieteke, et al.
Publicado: (2019)

Immunomics-Guided Antigen Discovery for Praziquantel-Induced Vaccination in Urogenital Human Schistosomiasis
por: Pearson, Mark S., et al.
Publicado: (2021)

Elevation of C-reactive protein, P-selectin and Resistin as potential inflammatory biomarkers of urogenital Schistosomiasis exposure in preschool children
por: Chimponda, Theresa N., et al.
Publicado: (2019)

Association between Micronutrients (Vitamin A, D, Iron) and Schistosome-Specific Cytokine Responses in Zimbabweans Exposed to Schistosoma haematobium
por: Reilly, Liam, et al.
Publicado: (2012)

Addressing vulnerability, building resilience: community-based adaptation to vector-borne diseases in the context of global change
por: Bardosh, Kevin Louis, et al.
Publicado: (2017)

Exposure, infection, systemic cytokine levels and antibody responses in young children concurrently exposed to schistosomiasis and malaria
por: IMAI, NATSUKO, et al.
Publicado: (2011)

The gut microbiome but not the resistome is associated with urogenital schistosomiasis in preschool-aged children
por: Osakunor, Derick N. M., et al.
Publicado: (2020)

Health Taxes on Tobacco, Alcohol, Food and Drinks in Low- and Middle-Income Countries: A Scoping Review of Policy Content, Actors, Process and Context
por: Elliott, Lana M., et al.
Publicado: (2020)

Regulatory and Activated T Cells in Human Schistosoma haematobium Infections
por: Nausch, Norman, et al.
Publicado: (2011)

Systemic Sclerosis in Zimbabwe: Autoantibody Biomarkers, Clinical, and Laboratory Correlates
por: Sibanda, Elopy N., et al.
Publicado: (2021)

Group 2 Innate Lymphoid Cell Proportions Are Diminished in Young Helminth Infected Children and Restored by Curative Anti-helminthic Treatment
por: Nausch, Norman, et al.
Publicado: (2015)

Seroepidemiology of Plasmodium species infections in Zimbabwean population
por: Amanfo, Seth A., et al.
Publicado: (2016)

Positive impact of preventative chemotherapy during a national helminth control program: Perception and KAP
por: Mutapi, Francisca, et al.
Publicado: (2020)

Drug metabolism and pharmacokinetics of praziquantel: A review of variable drug exposure during schistosomiasis treatment in human hosts and experimental models
por: Zdesenko, Grace, et al.
Publicado: (2020)

Cytokine responses to Schistosoma haematobium in a Zimbabwean population: contrasting profiles for IFN-γ, IL-4, IL-5 and IL-10 with age
por: Mutapi, Francisca, et al.
Publicado: (2007)

Schistosoma haematobium Treatment in 1–5 Year Old Children: Safety and Efficacy of the Antihelminthic Drug Praziquantel
por: Mutapi, Francisca, et al.
Publicado: (2011)

Multiplex peptide microarray profiling of antibody reactivity against neglected tropical diseases derived B-cell epitopes for serodiagnosis in Zimbabwe
por: Vengesai, Arthur, et al.
Publicado: (2022)

Field evaluation of a new antibody-based diagnostic for Schistosoma haematobium and S. mansoni at the point-of-care in northeast Zimbabwe
por: Nausch, Norman, et al.
Publicado: (2014)

Sources of heterogeneity in human monocyte subsets
por: Appleby, Laura J., et al.
Publicado: (2013)

Fungal allergic sensitisation in young rural Zimbabwean children: Gut mycobiome and seroreactivity characteristics
por: Pfavayi, Lorraine Tsitsi, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_vrle5s7u6eoh5rjlgp8lujiia8